Literature DB >> 16489611

Timing of treatment initiation in Parkinson's disease: a need for reappraisal?

Anthony H V Schapira1, Jose Obeso.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16489611     DOI： 10.1002/ana.20789

Source DB:  PubMed          Journal:  Ann Neurol        ISSN： 0364-5134            Impact factor:   10.422


× No keyword cloud information.
  36 in total

1.  Controversies in neurology: why monoamine oxidase B inhibitors could be a good choice for the initial treatment of Parkinson's disease.

Authors:  Matthias Löhle; Heinz Reichmann
Journal:  BMC Neurol       Date:  2011-09-22       Impact factor: 2.474

Review 2.  Monoamine oxidase B inhibitors for the treatment of Parkinson's disease: a review of symptomatic and potential disease-modifying effects.

Authors:  Anthony H V Schapira
Journal:  CNS Drugs       Date:  2011-12-01       Impact factor: 5.749

3.  Self-reported health in people with Parkinson's disease left untreated at diagnosis.

Authors:  Peter Hagell
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-11-29       Impact factor: 10.154

Review 4.  Parkinson's disease.

Authors:  C E Clarke
Journal:  BMJ       Date:  2007-09-01

5.  Pertinacious prescription of practice paradigms: the ethical burden of coercive clinical guidelines.

Authors:  William M Landau
Journal:  Curr Neurol Neurosci Rep       Date:  2007-09       Impact factor: 5.081

Review 6.  Disease modification in Parkinson's disease.

Authors:  Claire Henchcliffe; W Lawrence Severt
Journal:  Drugs Aging       Date:  2011-08-01       Impact factor: 3.923

Review 7.  Neuroprotection in Parkinson's disease: myth or reality?

Authors:  Tiffini Voss; Bernard Ravina
Journal:  Curr Neurol Neurosci Rep       Date:  2008-07       Impact factor: 5.081

8.  Parkinson's disease misdiagnosed as stroke.

Authors:  Robert Caslake; Kate S M Taylor; Carl E Counsell
Journal:  BMJ Case Rep       Date:  2009-02-02

Review 9.  The role of neuroplasticity in dopaminergic therapy for Parkinson disease.

Authors:  Xiaoxi Zhuang; Pietro Mazzoni; Un Jung Kang
Journal:  Nat Rev Neurol       Date:  2013-04-16       Impact factor: 42.937

10.  Efficacy of Rotigotine at Different Stages of Parkinson's Disease Symptom Severity and Disability: A Post Hoc Analysis According to Baseline Hoehn and Yahr Stage.

Authors:  Nir Giladi; Anthony P Nicholas; Mahnaz Asgharnejad; Elisabeth Dohin; Franz Woltering; Lars Bauer; Werner Poewe
Journal:  J Parkinsons Dis       Date:  2016-10-19       Impact factor: 5.568
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.